micro-community-banner
 
  • Saved

Did you know? Individuals with low health literacy are more likely to experience advanced stages of illness, leading to delayed diagnosis and treatment. This often results in poorer health outcomes, as patients may struggle to understand symptoms, navigate the healthcare system, or adhere to treatment plans. Addressing health literacy can improve early diagnosis and overall care quality.

How can improving health literacy help reduce delayed diagnoses and enhance health outcomes, especially for those with chronic conditions?

background

How can improving health literacy help reduce delayed diagnoses and enhance health outcomes, especially for those with chronic conditions?

Profile Image
  • Saved

Background Image DesktopBackground Image Mobile

Riboflavin (vitamin B2) is crucial for energy metabolism and biosynthetic processes as a precursor to flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). Deficiency is common and particularly affects women's health due to increased needs during hormonal fluctuations, pregnancy, and breastfeeding. Innovative strategies, like riboflavin-producing lactic acid bacteria, can enhance riboflavin intake while providing probiotic benefits. Lactobacillus species are especially important for vaginal health and gut microbiota. This review explores the molecular mechanisms and health benefits of riboflavin for women, emphasizing the synergistic potential of riboflavin-producing probiotics to meet dietary needs and support overall well-being.

Read More

Profile Image
  • Saved

Cardiovascular and physiological risk factors in women at mid-life and beyond - PubMed

Cardiovascular and physiological risk factors in women at mid-life and beyond - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38739947/

Cardiovascular disease (CVD) is the leading cause of death in women. After menopause, sex-specific and gender-specific factors may play an important role in increasing CVD risk, with changes in sex...

Menopause increases cardiovascular disease risk due to hormonal changes and metabolic shifts. This review explores menopause's impact on CVD, including estrogen's protective role, lipid levels, hypertension, and menopausal hormone therapy (MHT).

Profile Image
  • Saved

Unraveling sex-specific risks of knee osteoarthritis before menopause: Do sex differences start early in life? - PubMed

Unraveling sex-specific risks of knee osteoarthritis before menopause: Do sex differences start early in life? - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38703811/

We propose that to close the gap in health disparities, and specifically regarding OA, we should address sex-specific anatomic, biologic, and metabolic factors at early stages in life, as a...

This review explores the anatomical, injury-related, and metabolic factors contributing to sex-specific differences in knee osteoarthritis (OA) risk, highlighting early-life influences on women's higher OA incidence.

Profile Image
  • Saved

Insights from ESMO 2024: Advances in Breast Oncology

In this video, Dr. Sarah Telaney, a breast medical oncologist at Dana-Farber Cancer Institute, shares key takeaways from ESMO 2024, highlighting three impactful studies in breast oncology. She discusses the promising outcomes of preoperative pembrolizumab for early-stage triple-negative breast cancer, the significant efficacy of trastuzumab deruxtecan (T-DXd) in patients with metastatic HER2-positive disease and brain metastases, and the recently FDA-approved ribociclib for early-stage hormone receptor-positive breast cancer. Dr. Telaney emphasizes the exciting pace of drug development and its potential to improve patient care.

Profile Image